174533-98-3

Basic information

• Product Name: 2-(4-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID
• Synonyms: 2-(4-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID;2-(4-Hydroxyphenyl)-3H-benzimidazole-5-carboxylic acid;2-(4-Hydroxyphenyl)-1H-benzimidazole-5-carboxylic;2-(4-Hydroxyphenyl)-1H-benzimidazole-6-carboxylic acid;2-(4-Hydroxyphenyl)-3H-benzimidazole-5-carboxylic acid, 4-(6-Carboxy-1H-benzimidazol-2-yl)phenol;2-(4-Hydroxyphenyl)-1H-benzo[d]iMidazole-6-carboxylic acid;2-(4-hydroxyphenyl)-1H-1,3-benzodiazole-6-carboxylic acid
• CAS NO: 174533-98-3
• Molecular Formula: C14H10N2O3
• Molecular Weight: 254.24
• Mol File: 174533-98-3.mol

Chemical Properties

• Boiling Point: 595.545 °C at 760 mmHg
• Flash Point: 313.974 °C
• Appearance: /
• Density: 1.484 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.753
• CAS DataBase Reference: 2-(4-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID(174533-98-3)
• EPA Substance Registry System: 2-(4-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID(174533-98-3)

Safety Data

• Hazardous Substances Data: 174533-98-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-(4-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID is used as a medication for the treatment of acid-related disorders such as gastroesophageal reflux disease (GERD) and peptic ulcers. It serves as a proton pump inhibitor, reducing the production of stomach acid and providing relief from symptoms like heartburn and indigestion.
Used in Over-the-Counter Medications:
2-(4-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID is used as an active ingredient in over-the-counter antacid formulations, offering consumers a readily accessible solution for managing mild to moderate symptoms of acid reflux and heartburn.
Used in Prescription Medications:
2-(4-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID is used as a prescription drug for more severe cases of acid-related conditions, where a doctor's supervision is required to ensure proper dosage and management of potential side effects.
Used in Long-Term Management of Acid-Related Conditions:
2-(4-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID is used as a long-term treatment option for individuals with chronic acid reflux or ulcers, helping to maintain remission and prevent relapse by consistently reducing stomach acid levels.

InChI:InChI=1/C14H10N2O3/c17-10-4-1-8(2-5-10)13-15-11-6-3-9(14(18)19)7-12(11)16-13/h1-7,17H,(H,15,16)(H,18,19)

Upstream product

• 619-05-6 3,4-diaminobenzoic acid 
• 99-96-7 4-hydroxy-benzoic acid 
• 123-08-0 4-hydroxy-benzaldehyde 

Relevant articles and documents

Characterization, luminescent and magnetic analysis of five new lanthanide complexes based on carboxylate ligands

Five new lanthanide complexes, [Pr(HL1)(H2O)4]Cl2·2H2O (1), [Ho(HL1) (H2O)3]Cl2·2H2O (2), [Dy(HL1)(H2O)3]Cl2·2H2O (3), [Dy(H2L2)2(H2O)6]Cl3 (4) and [Ce(H2L3)(CH3CO2)2(H2O)2]·H2O (5), based on carboxylate ligands have been prepared. All complexes have been characterized via elemental analysis, single-crystal X-ray diffraction, powder X-ray diffraction and thermogravimetric analysis. According to single-crystal X-ray analysis, 1–3 and 5 are coordination polymers (CPs) with 1D zigzag chains, while 4 is a 0D structure. The 3D supramolecular structures of 1–4 are formed by the interaction of C/N ? H···Cl hydrogen bonds and π···π stacking interactions. In addition, the luminescent and magnetic properties of 1–5 have been discussed.

Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors

Breast cancer is the most frequent female cancer and second cause of cancer-related deaths among women around the world. Two thirds of breast cancer patients have hormone-dependent tumors, which is very likely be treated with hormonal therapy. Aromatase i

SYNTHESIS OF 2-(SUBSTITUTEDPHENYL)-5-(SUBSTITUTEDHETEROARYL)- 1H-BENZIMIDAZOLE DERIVATIVES AND INVESTIGATION OF THEIR BIOLOGICAL EFFECTS

The invention is related to the synthesis of 2-((5-(2-(4-Substitutedphenyl)-1H-benzo[d]imidazole-6-yl)-1,3,4-oxadiazole-2-yl)thio)-1-(4substitutedpiperazine-1-yl)-ethane-1-one derivative compounds and investigation of their biological effects. Cytotoxicity of the obtained compounds on 5 different cancer cell lines was evaluated and their selectivity indices were calculated.

Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison

In this study, some benzimidazole-oxadiazole derivatives were synthesised and tested for their in vitro anticancer activities on five cancer cell lines, including HeLa, MCF7, A549, HepG2 and C6. Their structures were elucidated by IR, 1H-NMR,